UE2343: Clinical Trials

1 trial of UE2343, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1
Phase 31Active not recruiting 1

Follow UE2343: new trials by email Literature Review of UE2343 trials Research Report on UE2343

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
Xanamem, Placebo - Dementia Moderate, Dementia, Mild
Phase 2 / Phase 3Active not recruitingActinogen Medical2472024-04-122026-10-21

Conditions studied

Alzheimer Disease (1)  ·  Dementia (1)  ·  Lymphoma, Follicular (1)

Sponsors

Actinogen Medical (1)

Countries

Australia (1)  ·  United States (1)